CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma

Published:2020-10-30 Issue:2 Volume:44 Page:345-355
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Yang Gang,Wang Yicheng^ORCID,Xiao Jianchun,Zhao Fangyu,Qiu Jiangdong,Liu Yueze,Chen Guangyu,Cao Zhe,You Lei,Zheng Lianfang,Zhang Taiping,Zhao Yupei

Funder

National Natural Science Foundation of China

Natural Science Foundation of Beijing

CAMS Innovation Fund for Medical Sciences

Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13402-020-00569-7.pdf

Reference49 articles.

1. R.L. Siegel, K.D. Miller, A. Jemal, Cancer statistics, 2019. CA Cancer J Clin 69, 7–34 (2019)

2. M. Hidalgo, Pancreatic cancer. N Engl J Med 362, 1605–1617 (2010)

3. S. Maeda, M. Unno, J. Yu, Adjuvant and neoadjuvant therapy for pancreatic cancer. J Pancreatol 2, 100–106 (2019)

4. D. Li, K. Xie, R. Wolff, J.L. Abbruzzese, Pancreatic cancer. Lancet 363, 1049–1057 (2004)

5. A. Fesler, J. Ju, Development of microRNA-based therapy for pancreatic cancer. J Pancreatol 2, 147–151 (2019)

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RPRD1B/CREPT facilitates the progression of diffuse large B-cell lymphoma by inhibiting apoptosis through the NF-κB signaling pathway;Asian Pacific Journal of Tropical Biomedicine;2024-07

2. CREPT/RPRD1B promotes tumorigenesis through STAT3-driven gene transcription in a p300-dependent manner;British Journal of Cancer;2021-02-03

3. CREPT is required for murine stem cell maintenance during intestinal regeneration;Nature Communications;2021-01-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3